BIOMERICA INC (BMRA) Current Ratio
- Current ratio · latest quarter: Value 1.62×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.62× | Current assets / current liabilities. $4.02M ÷ $2.48M ≈ 1.62× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.02M USD | Assets, Current |
| Current obligations | 2.48M USD | Liabilities, Current |
| Cash and equivalents | 1.31M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 785.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 1.71M USD | Inventory, Net |
| Payables | 377.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $4.02M | $2.48M | $1.31M | (m) | $785.00K | $1.71M | $377.00K | (m) | 1.62× |
| 2026-02-28 | $4.12M | $1.56M | $1.34M | (m) | $941.00K | $1.65M | (m) | (m) | 2.64× |
| 2025-11-30 | $5.19M | $1.60M | $2.54M | (m) | $947.00K | $1.52M | (m) | (m) | 3.25× |
| 2025-08-31 | $5.90M | $1.69M | $3.05M | (m) | $1.21M | $1.47M | (m) | (m) | 3.48× |
| 2025-05-31 | $4.88M | $1.74M | $2.40M | (m) | $731.00K | $1.49M | $295.00K | (m) | 2.80× |
| 2025-05-13 | $4.88M | $1.74M | $2.40M | (m) | $731.00K | $1.49M | (m) | (m) | 2.80× |
| 2025-02-28 | $6.20M | $1.65M | $3.06M | (m) | $1.27M | $1.66M | (m) | (m) | 3.76× |
| 2024-11-30 | $5.95M | $1.88M | $2.37M | (m) | $1.33M | $1.79M | (m) | (m) | 3.17× |
| 2024-08-31 | $6.45M | $2.15M | $2.82M | (m) | $1.55M | $1.94M | (m) | (m) | 3.00× |
| 2024-05-31 | $7.73M | $2.20M | $4.17M | (m) | $947.00K | $2.38M | $560.00K | (m) | 3.51× |
| 2024-02-29 | $8.85M | $1.99M | $5.32M | (m) | $1.13M | $2.13M | (m) | (m) | 4.44× |
| 2023-11-30 | $10.27M | $1.82M | $7.13M | (m) | $1.07M | $1.84M | (m) | (m) | 5.63× |
| 2023-08-31 | $11.57M | $1.75M | $7.99M | (m) | $1.43M | $1.88M | (m) | (m) | 6.63× |
| 2023-05-31 | $12.80M | $1.95M | $9.72M | (m) | $722.00K | $2.06M | $344.00K | (m) | 6.58× |
| 2023-02-28 | $6.48M | $1.40M | $3.35M | (m) | $754.56K | $2.06M | (m) | (m) | 4.65× |
| 2022-11-30 | $8.10M | $1.76M | $5.07M | (m) | $850.01K | $2.06M | (m) | (m) | 4.59× |
| 2022-08-31 | $9.17M | $1.76M | $6.08M | (m) | $932.27K | $1.92M | (m) | (m) | 5.22× |
| 2022-05-31 | $9.43M | $2.01M | $5.92M | (m) | $774.00K | $2.42M | $736.00K | (m) | 4.69× |
| 2022-02-28 | $15.23M | $6.70M | $10.17M | (m) | $1.16M | $3.23M | (m) | (m) | 2.27× |
| 2021-11-30 | $12.40M | $4.74M | $7.20M | (m) | $1.13M | $2.98M | (m) | (m) | 2.62× |
| 2021-08-31 | $8.95M | $1.48M | $5.00M | (m) | $772.19K | $2.86M | (m) | (m) | 6.04× |
| 2021-05-31 | $9.23M | $1.30M | $4.20M | (m) | $1.46M | $3.21M | $431.00K | (m) | 7.10× |
| 2021-02-28 | $10.78M | $1.35M | $5.27M | (m) | $1.88M | $2.86M | (m) | (m) | 7.98× |
| 2020-11-30 | $11.95M | $1.87M | $5.68M | (m) | $1.61M | $4.20M | (m) | (m) | 6.38× |
| 2020-08-31 | $13.12M | $1.80M | $6.96M | (m) | $1.58M | $4.10M | (m) | (m) | 7.28× |
| 2020-05-31 | $14.77M | $1.48M | $8.64M | (m) | $1.77M | $2.85M | $833.41K | (m) | 10.00× |
| 2020-02-29 | $5.74M | $1.91M | $2.39M | (m) | $962.32K | $2.19M | $1.27M | (m) | 3.01× |
| 2019-11-30 | $4.51M | $1.98M | $850.99K | (m) | $1.28M | $2.19M | $1.34M | (m) | 2.27× |
| 2019-08-31 | $4.11M | $1.37M | $807.55K | (m) | $858.51K | $2.21M | $943.88K | (m) | 3.01× |
| 2019-05-31 | $4.49M | $1.26M | $686.78K | (m) | $1.45M | $2.15M | (m) | (m) | 3.56× |
| 2019-02-28 | $4.33M | $1.11M | $917.93K | (m) | $1.08M | $2.08M | (m) | (m) | 3.89× |
| 2018-11-30 | $4.69M | $1.02M | $1.12M | (m) | $1.26M | $2.12M | (m) | (m) | 4.61× |
| 2018-08-31 | $4.12M | $797.53K | $583.69K | (m) | $1.01M | $2.21M | (m) | (m) | 5.16× |
| 2018-05-31 | $4.48M | $896.81K | $1.20M | (m) | $799.94K | $2.18M | (m) | (m) | 5.00× |
| 2018-02-28 | $4.05M | $759.30K | $597.03K | (m) | $1.16M | $1.95M | (m) | (m) | 5.33× |
| 2017-11-30 | $4.10M | $804.39K | $817.81K | (m) | $1.06M | $1.83M | $585.70K | (m) | 5.10× |
| 2017-08-31 | $4.17M | $626.72K | $1.08M | (m) | $1.05M | $1.79M | $418.91K | (m) | 6.66× |
| 2017-05-31 | $4.21M | $528.87K | $1.23M | (m) | $1.06M | $1.73M | (m) | (m) | 7.96× |
| 2017-02-28 | $4.64M | $656.74K | $1.54M | (m) | $1.07M | $1.82M | (m) | (m) | 7.07× |
| 2016-11-30 | $4.77M | $566.52K | $1.61M | (m) | $1.14M | $1.88M | $367.16K | (m) | 8.42× |
| 2016-08-31 | $4.77M | $444.91K | $1.82M | (m) | $969.02K | $1.85M | (m) | (m) | 10.72× |
| 2016-05-31 | $4.84M | $506.03K | $1.89M | (m) | $969.47K | $1.86M | (m) | (m) | 9.55× |
| 2016-02-29 | $3.98M | $486.84K | $859.14K | (m) | $919.94K | $2.10M | (m) | (m) | 8.18× |
| 2015-11-30 | $4.16M | $469.09K | $642.98K | (m) | $1.17M | $2.24M | $293.33K | (m) | 8.86× |
| 2015-08-31 | $4.46M | $539.15K | $893.26K | (m) | $1.21M | $2.11M | $375.32K | (m) | 8.28× |
| 2015-05-31 | $4.39M | $523.93K | $1.09M | (m) | $1.11M | $2.03M | (m) | (m) | 8.38× |
| 2015-02-28 | $4.43M | $483.37K | $1.17M | (m) | $931.39K | $2.11M | (m) | (m) | 9.17× |
| 2014-11-30 | $4.47M | $466.99K | $1.67M | (m) | $563.91K | $1.99M | $249.98K | (m) | 9.56× |
| 2014-08-31 | $4.54M | $348.73K | $1.65M | (m) | $788.20K | $1.88M | $178.16K | (m) | 13.01× |
| 2014-05-31 | $4.91M | $555.84K | $1.51M | (m) | $1.45M | $1.77M | (m) | (m) | 8.84× |
| 2014-02-28 | $5.06M | $543.45K | $1.67M | (m) | $1.17M | $1.94M | $317.46K | (m) | 9.31× |
| 2013-11-30 | $4.70M | $400.59K | $1.65M | (m) | $821.57K | $1.90M | $167.81K | (m) | 11.73× |
| 2013-08-31 | $5.11M | $536.50K | $2.09M | (m) | $903.25K | $1.79M | $215.99K | (m) | 9.52× |
| 2013-05-31 | $5.25M | $559.89K | $2.47M | (m) | $871.66K | $1.57M | $282.14K | (m) | 9.38× |
| 2013-02-28 | $4.94M | $584.10K | $2.32M | (m) | $513.31K | $1.71M | $194.54K | (m) | 8.45× |
| 2012-11-30 | $4.84M | $545.68K | $1.19M | (m) | (m) | $1.80M | $225.98K | (m) | 8.87× |
| 2012-08-31 | $4.89M | $710.26K | $1.30M | (m) | (m) | $1.82M | $338.42K | (m) | 6.88× |
| 2012-05-31 | $4.49M | $592.29K | $1.08M | (m) | $1.20M | $1.82M | $187.62K | (m) | 7.58× |
| 2012-02-29 | $4.41M | $662.64K | $898.46K | (m) | (m) | $1.86M | (m) | (m) | 6.66× |
| 2011-11-30 | $4.01M | $422.13K | $965.97K | (m) | (m) | $1.67M | (m) | (m) | 9.51× |
| 2011-08-31 | $3.88M | $523.56K | $1.02M | (m) | (m) | $1.74M | (m) | (m) | 7.41× |
| 2011-05-31 | $3.89M | $625.01K | $989.27K | (m) | (m) | $1.79M | $246.35K | (m) | 6.22× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |